Legend Biotech Receives Outperform Rating from Royal Bank of Canada - MarketBeat

LEGN Stock  USD 35.78  1.05  3.02%   
About 58% of all Legend Biotech's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Legend Biotech Corp suggests that some traders are interested. Legend Biotech's investing sentiment overview a quick insight into current market opportunities from investing in Legend Biotech Corp. Many technical investors use Legend Biotech Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Legend Biotech Receives Outperform Rating from Royal Bank of Canada MarketBeat

Read at news.google.com
Google News at Macroaxis
  

Legend Biotech Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Legend Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Legend Biotech Maximum Pain Price Across January 17th 2025 Option Contracts

Legend Biotech's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Legend Biotech close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Legend Biotech's options.

Legend Biotech Fundamental Analysis

We analyze Legend Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Employees

Number Of Employees Comparative Analysis

Legend Biotech is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Legend Biotech Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Legend Biotech stock to make a market-neutral strategy. Peer analysis of Legend Biotech could also be used in its relative valuation, which is a method of valuing Legend Biotech by comparing valuation metrics with similar companies.

Peers

Legend Biotech Related Equities

AMLXAmylyx Pharmaceuticals   6.14   
0%
100.0%
ZLABZai Lab   1.98   
0%
32.0%
STOKStoke Therapeutics   1.95   
0%
31.0%
MDGLMadrigal Pharmaceuticals   1.88   
0%
30.0%
PLRXPliant Therapeutics   1.88   
0%
30.0%
PCVXVaxcyte   1.87   
0%
30.0%
ASNDAscendis Pharma   1.74   
0%
28.0%
TERNTerns Pharmaceuticals   1.41   
0%
22.0%
BPMCBlueprint Medicines   1.32   
0%
21.0%
APLSApellis Pharmaceuticals   0.90   
0%
14.0%
AKROAkero Therapeutics   0.57   
0%
9.0%
ACLXArcellx   0.48   
0%
7.0%
ALNYAlnylam Pharmaceuticals   0.28   
0%
4.0%
ETNB89bio   0.25   
4.0%
0%
TVTXTravere Therapeutics   0.58   
9.0%
0%
DAWNDay One   0.94   
15.0%
0%
When determining whether Legend Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotech Corp Stock:
Check out Legend Biotech Hype Analysis, Legend Biotech Correlation and Legend Biotech Performance.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.92)
Revenue Per Share
2.851
Quarterly Revenue Growth
0.669
Return On Assets
(0.12)
Return On Equity
(0.28)
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.